MCI patients also showed a decreased GSH/GSSG ratio and a reduction in SOD and GST activity in the hippocampus compared to age-matched controls [218], which suggests that alterations in GSH metabolism may be considered as an early biomarker of AD onset. Here, SOD1 is linked to Alzheimer disease.